CRC screening uptake no better with use of fecal immunochemical testing in at-risk individuals

by

For first-degree relatives of patients with nonsyndromic colorectal cancer (CRC), fecal immunochemical testing (FIT) screening does not improve screening uptake compared with colonoscopy screening, according to a study published online Oct. 24 in PLOS Medicine.

Leave A Comment

Your email address will not be published. Required fields are marked *